Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) stock most popular amongst private equity firms who own 48%, while individual investors hold 27% [Yahoo! Finance]
Lexicon Pharmaceuticals, Inc. (LXRX)
Last lexicon pharmaceuticals, inc. earnings: 4/27 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
lexpharma.com/investors
Company Research
Source: Yahoo! Finance
59% of the business is held by the top 2 shareholders 24% of Lexicon Pharmaceuticals is held by Institutions Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. Every investor in Lexicon Pharmaceuticals, Inc. ( NASDAQ:LXRX ) should be aware of the most powerful shareholder groups. And the group that holds the biggest piece of the pie are private equity firms with 48% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn). Individual investors, on the other hand, account for 27% of the company's stockholders. Let's delve deeper into each type of owner of Lexicon Pharmaceuticals, beginning with the chart below. View our latest analysis for Lexicon Pharmaceuticals Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a majo
Show less
Read more
Impact Snapshot
Event Time:
LXRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LXRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LXRX alerts
High impacting Lexicon Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
LXRX
News
- Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private PlacementGlobeNewswire
- Lexicon Announces Pricing of Approximately $94.6 Million Public Offering and Concurrent Private PlacementGlobeNewswire
- Lexicon Announces Proposed Public Offering of Common StockGlobeNewswire
- How A Reset Price Target Is Reframing The Story For Lexicon Pharmaceuticals (LXRX) [Yahoo! Finance]Yahoo! Finance
- Lexicon Pharmaceuticals to Ring the Nasdaq Closing Bell on January 27, 2026 to Celebrate 30th Anniversary [Yahoo! Finance]Yahoo! Finance
LXRX
Earnings
- 11/6/25 - Beat
LXRX
Sec Filings
- 2/19/26 - Form 4
- 2/18/26 - Form 4
- 2/17/26 - Form PRE
- LXRX's page on the SEC website